|
1.
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2.
|
Lung T, Tascau OC, Almasan HA and Mureşan
O: Head and neck cancer, treatment, evolution and post therapeutic
survival - Part 2: a decade’s results 1993–2002. J Craniomaxillofac
Surg. 35:126–131. 2007.PubMed/NCBI
|
|
3.
|
Gondos A, Arndt V, Holleczek B, et al:
Cancer survival in Germany and the United States at the beginning
of the 21st century: an up-to-date comparison by period analysis.
Int J Cancer. 121:395–400. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Hunter KD, Parkinson EK and Harrison PR:
Profiling early head and neck cancer. Nat Rev Cancer. 5:127–135.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Warnakulasuriya S, Johnson NW and van der
Waal I: Nomenclature and classification of potentially malignant
disorders of the mucosa. J Oral Pathol Med. 36:575–580. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Fleskens S and Slootweg P: Grading systems
in head and neck dysplasia: their prognostic value, weaknesses and
utility. Head Neck Oncol. 1:11–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Warnakulasuriya S, Reibel J, Bouquot J and
Dabelsteen E: Oral epithelial dysplasia classification systems:
predictive value, utility, weaknesses and scope for improvement. J
Oral Pathol Med. 37:127–133. 2008. View Article : Google Scholar
|
|
8.
|
Van der Waal I: Potentially malignant
disorders of the oral and oropharyngeal mucosa; terminology,
classification and present concepts of management. Oral Oncol.
45:317–323. 2009.PubMed/NCBI
|
|
9.
|
Pindborg JJ, Reichart PA, Smith CJ and van
der Waal I: World Health Organization: Histological Typing of
Cancer and Precancer of the Oral Mucosa. 14. Springer-Verlag;
Berlin: pp. 47–62. 1997
|
|
10.
|
Reibel J: Prognosis of oral pre-malignant
lesions: significance of clinical, histopathological, and molecular
biological characteristics. Crit Rev Oral Biol Med. 14:47–62. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Holmstrup P, Vedtofte P, Reibel J and
Stoltze K: Oral premalignant lesions: is a biopsy reliable? J Oral
Pathol Med. 36:262–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Fleskens SA, Bergshoeff VE, Voogd AC, et
al: Interobserver variability of laryngeal mucosal premalignant
lesions: a histopathological evaluation. Mod Pathol. 24:892–898.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Brennan M, Migliorati CA, Lockhart PB, et
al: Management of oral epithelial dysplasia: a review. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 103(Suppl 19): e1–e12.
2007. View Article : Google Scholar
|
|
14.
|
Warnakulasuriya S: Lack of molecular
markers to predict malignant potential of oral precancer. J Pathol.
190:407–409. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Ha PK, Chang SS, Glazer CA, et al:
Molecular techniques and genetic alterations in head and neck
cancer. Oral Oncol. 45:335–339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Pitiyage G, Tilakaratne WM, Tavassoli M
and Warnakulasuriya S: Molecular markers in oral epithelial
dysplasia: review. J Oral Pathol Med. 38:737–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Nasser W, Flechtenmacher C, Holzinger D,
et al: Aberrant expression of p53, p16(INK4a) and Ki-67 as basic
biomarker for malignant progression of oral leukoplakias. J Oral
Pathol Med. 40:629–635. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Vairaktaris E, Yapijakis C, Derka S, et
al: Association of platelet glycoprotein Ia polymorphism with minor
increase of risk for oral cancer. Eur J Surg Oncol. 32:455–457.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Vairaktaris E, Yapijakis C, Yiannopoulos
A, et al: Strong association of the tissue inhibitor of
metalloproteinase-2 polymorphism with an increased risk of oral
squamous cell carcinoma in Europeans. Oncol Rep. 17:963–968.
2007.PubMed/NCBI
|
|
20.
|
Yapijakis C, Vairaktaris E, Vassiliou S,
et al: The low VEGF production allele of the +936C/T polymorphism
is strongly associated with increased risk for oral cancer. J
Cancer Res Clin Oncol. 133:787–791. 2007.
|
|
21.
|
Jungbluth AA, Busam KJ, Kolb D, et al:
Expression of MAGE-antigens in normal tissues and cancer. Int J
Cancer. 85:460–465. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Muller-Richter UD, Dowejko A, Peters S, et
al: MAGE-A antigens in patients with primary oral squamous cell
carcinoma. Clin Oral Investig. 14:291–296. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Ries J, Mollaoglu N, Toyoshima T, et al: A
novel multiple-marker method for the early diagnosis of oral
squamous cell carcinoma. Dis Markers. 27:75–84. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Krauss E, Rauthe S, Gattenlohner S, et al:
MAGE-A antigens in lesions of the oral mucosa. Clin Oral Investig.
15:315–320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Metzler P, Mollaoglu N, Schwarz S, et al:
MAGE-A as a novel approach in the diagnostic accuracy of oral
squamous cell cancer: a case report. Head Neck Oncol. 39:1–6.
2009.PubMed/NCBI
|
|
26.
|
Ries J, Ponader S, Mollaoglu N, et al:
Early findings of a novel established molecular diagnostic
technique for the prediction of malignant transformation in
leukoplakia. Mol Med Rep. 2:947–952. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Mecklenburg I, Weckermann D, Zippelius A,
et al: A multi-marker real-time RT-PCR for MAGE-A gene expression
allows sensitive detection and quantification of the minimal
systemic tumor load in patients with localized cancer. J Immunol
Methods. 323:180–193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Scheifele C and Reichart PA: Is there a
natural limit of the transformation rate of oral leukoplakia? Oral
Oncol. 39:470–475. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Scheifele C and Reichart PA: Oral
leukoplakia in manifest squamous epithelial carcinoma. A clinical
prospective study of 101 patients. Mund Kiefer Gesichtschir.
2:326–330. 1998.(In German).
|
|
30.
|
Rethman MP, Carpenter W, Cohen EE, et al:
Evidence-based clinical recommendations regarding screening for
oral squamous cell carcinomas. J Am Dent Assoc. 141:509–520. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Oliveira LR and Ribeiro-Silva A:
Prognostic significance of immunohistochemical biomarkers in oral
squamous cell carcinoma. Int J Oral Maxillofac Surg. 40:298–307.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Ehrlich M: DNA methylation in cancer: too
much, but also too little. Oncogene. 21:5400–5413. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Diez-Perez R, Campo-Trapero J,
Cano-Sanchez J, et al: Methylation in oral cancer and pre-cancerous
lesions (Review). Oncol Rep. 25:1203–1209. 2011.PubMed/NCBI
|
|
34.
|
Simpson AJ, Caballero OL, Jungbluth A, et
al: Cancer/testis antigens, gametogenesis and cancer. Nat Rev
Cancer. 5:615–625. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
35.
|
De Smet C, Loriot A and Boon T:
Promoter-dependent mechanism leading to selective hypomethylation
within the 5′ region of gene MAGE-A1 in tumor cells. Mol Cell Biol.
24:4781–4790. 2004.PubMed/NCBI
|
|
36.
|
Ries J, Schultze-Mosgau S, Neukam F, et
al: Investigation of the expression of melanoma antigen-encoding
genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to
determine potential targets for gene-based cancer immunotherapy.
Int J Oncol. 26:817–824. 2005.PubMed/NCBI
|
|
37.
|
Ries J, Vairaktaris E, Mollaoglu N, et al:
Expression of melanoma-associated antigens in oral squamous cell
carcinoma. J Oral Pathol Med. 37:88–93. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Sang M, Lian Y, Zhou X and Shan B: MAGE-A
family: Attractive targets for cancer immunotherapy. Vaccine.
29:8496–8500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Atanackovic D, Blum I, Cao Y, et al:
Expression of cancer-testis antigens as possible targets for
antigen-specific immunotherapy in head and neck squamous cell
carcinoma. Cancer Biol Ther. 5:1218–1225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Rapidis AD and Wolf GT: Immunotherapy of
head and neck cancer: current and future considerations. J Oncol.
2009:3463452009. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Lingen MW, Kalmar JR, Karrison T and
Speight PM: Critical evaluation of diagnostic aids for the
detection of oral cancer. Oral Oncol. 44:10–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Mollaoglu N, Metzler P, Zenk J, et al:
Prediction of recurrence using exfoliative cytology and
melanoma-associated antigen-A mRNA analysis following wide excision
of oral squamous cell carcinoma: short report. Cytopathology.
22:387–391. 2011. View Article : Google Scholar
|
